Hypertension and non-insulin dependent diabetes.

of angiotensin converting enzyme are also under way; animal studies have shown that they limit the proliferative response to vascular injury.'5 Future treatments might include specific monoclonal antibodies, which can block receptors for platelet adhesion or mitogens such as platelet derived growth factor.